希少疾患治療の世界市場（～2026年）

• 英文タイトル：Global Rare Disease Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY04458
• 出版社/出版日：QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、129ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料は希少疾患治療のグローバル市場について調査・分析したレポートです。種類別（オリジネーター医薬品、ジェネリック医薬品）市場規模、用途別（病院薬局、専門薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別希少疾患治療の競争状況、市場シェア
・世界の希少疾患治療市場：種類別市場規模 2015年-2020年（オリジネーター医薬品、ジェネリック医薬品）
・世界の希少疾患治療市場：種類別市場規模予測 2021年-2026年（オリジネーター医薬品、ジェネリック医薬品）
・世界の希少疾患治療市場：用途別市場規模 2015年-2020年（病院薬局、専門薬局、小売薬局）
・世界の希少疾患治療市場：用途別市場規模予測 2021年-2026年（病院薬局、専門薬局、小売薬局）
・北米の希少疾患治療市場分析：米国、カナダ
・ヨーロッパの希少疾患治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの希少疾患治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の希少疾患治療市場分析：メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの希少疾患治療市場分析：トルコ、サウジアラビア、UAE等
・企業情報（企業概要、製品概要、販売量、企業動向）
- 掲載企業（変更可能性あり）：Novartis、Pfizer、F. Hoffmann-La Roche、Celgene、AbbVie、Johnson & Johnson、Takeda、Alexion、Novo Nordisk、Sanofi、Bayer、Amgen、Allergan、Eisai、Bristol-Myers Squibb、Merck、Vertex Pharmaceuticals、Baxter、BioMarin、Teva Pharmaceutical Industries
・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

A rare disease is any disease that affects a small percentage of the population.
Most rare diseases are genetic and thus are present throughout the person’s entire life, even if symptoms do not immediately appear.

Market Analysis and Insights: Global Rare Disease Treatment Market
The global Rare Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Rare Disease Treatment Scope and Market Size
Rare Disease Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Rare Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Novartis
Pfizer
F. Hoffmann-La Roche
Celgene
AbbVie
Johnson & Johnson
Takeda
Alexion
Novo Nordisk
Sanofi
Bayer
Amgen
Allergan
Eisai
Bristol-Myers Squibb
Merck
Vertex Pharmaceuticals
Baxter
BioMarin
Teva Pharmaceutical Industries

Market segment by Type, the product can be split into
Originator Drugs
Generic Drugs
Market segment by Application, split into
Hospital Pharmacies
Specialty Pharmacies
Retail Pharmacies

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Rare Disease Treatment Revenue
1.4 Market by Type
1.4.1 Global Rare Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Originator Drugs
1.4.3 Generic Drugs
1.5 Market by Application
1.5.1 Global Rare Disease Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Specialty Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Rare Disease Treatment Market Perspective (2015-2026)
2.2 Global Rare Disease Treatment Growth Trends by Regions
2.2.1 Rare Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Rare Disease Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Rare Disease Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Rare Disease Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Rare Disease Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Rare Disease Treatment Players by Market Size
3.1.1 Global Top Rare Disease Treatment Players by Revenue (2015-2020)
3.1.2 Global Rare Disease Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Rare Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Rare Disease Treatment Market Concentration Ratio
3.2.1 Global Rare Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Rare Disease Treatment Revenue in 2019
3.3 Rare Disease Treatment Key Players Head office and Area Served
3.4 Key Players Rare Disease Treatment Product Solution and Service
3.5 Date of Enter into Rare Disease Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Rare Disease Treatment Historic Market Size by Type (2015-2020)
4.2 Global Rare Disease Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Rare Disease Treatment Market Size by Application (2015-2020)
5.2 Global Rare Disease Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Rare Disease Treatment Market Size (2015-2020)
6.2 Rare Disease Treatment Key Players in North America (2019-2020)
6.3 North America Rare Disease Treatment Market Size by Type (2015-2020)
6.4 North America Rare Disease Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Rare Disease Treatment Market Size (2015-2020)
7.2 Rare Disease Treatment Key Players in Europe (2019-2020)
7.3 Europe Rare Disease Treatment Market Size by Type (2015-2020)
7.4 Europe Rare Disease Treatment Market Size by Application (2015-2020)

8 China
8.1 China Rare Disease Treatment Market Size (2015-2020)
8.2 Rare Disease Treatment Key Players in China (2019-2020)
8.3 China Rare Disease Treatment Market Size by Type (2015-2020)
8.4 China Rare Disease Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Rare Disease Treatment Market Size (2015-2020)
9.2 Rare Disease Treatment Key Players in Japan (2019-2020)
9.3 Japan Rare Disease Treatment Market Size by Type (2015-2020)
9.4 Japan Rare Disease Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Rare Disease Treatment Market Size (2015-2020)
10.2 Rare Disease Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Rare Disease Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Rare Disease Treatment Market Size by Application (2015-2020)

11 India
11.1 India Rare Disease Treatment Market Size (2015-2020)
11.2 Rare Disease Treatment Key Players in India (2019-2020)
11.3 India Rare Disease Treatment Market Size by Type (2015-2020)
11.4 India Rare Disease Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Rare Disease Treatment Market Size (2015-2020)
12.2 Rare Disease Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Rare Disease Treatment Market Size by Type (2015-2020)
12.4 Central & South America Rare Disease Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Novartis
13.1.1 Novartis Company Details
13.1.2 Novartis Business Overview
13.1.3 Novartis Rare Disease Treatment Introduction
13.1.4 Novartis Revenue in Rare Disease Treatment Business (2015-2020))
13.1.5 Novartis Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Rare Disease Treatment Introduction
13.2.4 Pfizer Revenue in Rare Disease Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 F. Hoffmann-La Roche
13.3.1 F. Hoffmann-La Roche Company Details
13.3.2 F. Hoffmann-La Roche Business Overview
13.3.3 F. Hoffmann-La Roche Rare Disease Treatment Introduction
13.3.4 F. Hoffmann-La Roche Revenue in Rare Disease Treatment Business (2015-2020)
13.3.5 F. Hoffmann-La Roche Recent Development
13.4 Celgene
13.4.1 Celgene Company Details
13.4.2 Celgene Business Overview
13.4.3 Celgene Rare Disease Treatment Introduction
13.4.4 Celgene Revenue in Rare Disease Treatment Business (2015-2020)
13.4.5 Celgene Recent Development
13.5 AbbVie
13.5.1 AbbVie Company Details
13.5.2 AbbVie Business Overview
13.5.3 AbbVie Rare Disease Treatment Introduction
13.5.4 AbbVie Revenue in Rare Disease Treatment Business (2015-2020)
13.5.5 AbbVie Recent Development
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview
13.6.3 Johnson & Johnson Rare Disease Treatment Introduction
13.6.4 Johnson & Johnson Revenue in Rare Disease Treatment Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development
13.7 Takeda
13.7.1 Takeda Company Details
13.7.2 Takeda Business Overview
13.7.3 Takeda Rare Disease Treatment Introduction
13.7.4 Takeda Revenue in Rare Disease Treatment Business (2015-2020)
13.7.5 Takeda Recent Development
13.8 Alexion
13.8.1 Alexion Company Details
13.8.2 Alexion Business Overview
13.8.3 Alexion Rare Disease Treatment Introduction
13.8.4 Alexion Revenue in Rare Disease Treatment Business (2015-2020)
13.8.5 Alexion Recent Development
13.9 Novo Nordisk
13.9.1 Novo Nordisk Company Details
13.9.2 Novo Nordisk Business Overview
13.9.3 Novo Nordisk Rare Disease Treatment Introduction
13.9.4 Novo Nordisk Revenue in Rare Disease Treatment Business (2015-2020)
13.9.5 Novo Nordisk Recent Development
13.10 Sanofi
13.10.1 Sanofi Company Details
13.10.2 Sanofi Business Overview
13.10.3 Sanofi Rare Disease Treatment Introduction
13.10.4 Sanofi Revenue in Rare Disease Treatment Business (2015-2020)
13.10.5 Sanofi Recent Development
13.11 Bayer
10.11.1 Bayer Company Details
10.11.2 Bayer Business Overview
10.11.3 Bayer Rare Disease Treatment Introduction
10.11.4 Bayer Revenue in Rare Disease Treatment Business (2015-2020)
10.11.5 Bayer Recent Development
13.12 Amgen
10.12.1 Amgen Company Details
10.12.2 Amgen Business Overview
10.12.3 Amgen Rare Disease Treatment Introduction
10.12.4 Amgen Revenue in Rare Disease Treatment Business (2015-2020)
10.12.5 Amgen Recent Development
13.13 Allergan
10.13.1 Allergan Company Details
10.13.2 Allergan Business Overview
10.13.3 Allergan Rare Disease Treatment Introduction
10.13.4 Allergan Revenue in Rare Disease Treatment Business (2015-2020)
10.13.5 Allergan Recent Development
13.14 Eisai
10.14.1 Eisai Company Details
10.14.2 Eisai Business Overview
10.14.3 Eisai Rare Disease Treatment Introduction
10.14.4 Eisai Revenue in Rare Disease Treatment Business (2015-2020)
10.14.5 Eisai Recent Development
13.15 Bristol-Myers Squibb
10.15.1 Bristol-Myers Squibb Company Details
10.15.2 Bristol-Myers Squibb Business Overview
10.15.3 Bristol-Myers Squibb Rare Disease Treatment Introduction
10.15.4 Bristol-Myers Squibb Revenue in Rare Disease Treatment Business (2015-2020)
10.15.5 Bristol-Myers Squibb Recent Development
13.16 Merck
10.16.1 Merck Company Details
10.16.2 Merck Business Overview
10.16.3 Merck Rare Disease Treatment Introduction
10.16.4 Merck Revenue in Rare Disease Treatment Business (2015-2020)
10.16.5 Merck Recent Development
13.17 Vertex Pharmaceuticals
10.17.1 Vertex Pharmaceuticals Company Details
10.17.2 Vertex Pharmaceuticals Business Overview
10.17.3 Vertex Pharmaceuticals Rare Disease Treatment Introduction
10.17.4 Vertex Pharmaceuticals Revenue in Rare Disease Treatment Business (2015-2020)
10.17.5 Vertex Pharmaceuticals Recent Development
13.18 Baxter
10.18.1 Baxter Company Details
10.18.2 Baxter Business Overview
10.18.3 Baxter Rare Disease Treatment Introduction
10.18.4 Baxter Revenue in Rare Disease Treatment Business (2015-2020)
10.18.5 Baxter Recent Development
13.19 BioMarin
10.19.1 BioMarin Company Details
10.19.2 BioMarin Business Overview
10.19.3 BioMarin Rare Disease Treatment Introduction
10.19.4 BioMarin Revenue in Rare Disease Treatment Business (2015-2020)
10.19.5 BioMarin Recent Development
13.20 Teva Pharmaceutical Industries
10.20.1 Teva Pharmaceutical Industries Company Details
10.20.2 Teva Pharmaceutical Industries Business Overview
10.20.3 Teva Pharmaceutical Industries Rare Disease Treatment Introduction
10.20.4 Teva Pharmaceutical Industries Revenue in Rare Disease Treatment Business (2015-2020)
10.20.5 Teva Pharmaceutical Industries Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Rare Disease Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Rare Disease Treatment Revenue
Table 3. Ranking of Global Top Rare Disease Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Rare Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Originator Drugs
Table 6. Key Players of Generic Drugs
Table 7. Global Rare Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Rare Disease Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Rare Disease Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Rare Disease Treatment Market Share by Regions (2015-2020)
Table 11. Global Rare Disease Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Rare Disease Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Rare Disease Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Rare Disease Treatment Players
Table 18. Global Rare Disease Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Rare Disease Treatment Market Share by Players (2015-2020)
Table 20. Global Top Rare Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Disease Treatment as of 2019)
Table 21. Global Rare Disease Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Rare Disease Treatment Product Solution and Service
Table 24. Date of Enter into Rare Disease Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Rare Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Rare Disease Treatment Market Size Share by Type (2015-2020)
Table 28. Global Rare Disease Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Rare Disease Treatment Market Size Share by Application (2015-2020)
Table 30. Global Rare Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Rare Disease Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Rare Disease Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Rare Disease Treatment Market Share (2019-2020)
Table 34. North America Rare Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Rare Disease Treatment Market Share by Type (2015-2020)
Table 36. North America Rare Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Rare Disease Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Rare Disease Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Rare Disease Treatment Market Share (2019-2020)
Table 40. Europe Rare Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Rare Disease Treatment Market Share by Type (2015-2020)
Table 42. Europe Rare Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Rare Disease Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Rare Disease Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Rare Disease Treatment Market Share (2019-2020)
Table 46. China Rare Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Rare Disease Treatment Market Share by Type (2015-2020)
Table 48. China Rare Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Rare Disease Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Rare Disease Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Rare Disease Treatment Market Share (2019-2020)
Table 52. Japan Rare Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Rare Disease Treatment Market Share by Type (2015-2020)
Table 54. Japan Rare Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Rare Disease Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Rare Disease Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Rare Disease Treatment Market Share (2019-2020)
Table 58. Southeast Asia Rare Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Rare Disease Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Rare Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Rare Disease Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Rare Disease Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Rare Disease Treatment Market Share (2019-2020)
Table 64. India Rare Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Rare Disease Treatment Market Share by Type (2015-2020)
Table 66. India Rare Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Rare Disease Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Rare Disease Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Rare Disease Treatment Market Share (2019-2020)
Table 70. Central & South America Rare Disease Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Rare Disease Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Rare Disease Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Rare Disease Treatment Market Share by Application (2015-2020)
Table 74. Novartis Company Details
Table 75. Novartis Business Overview
Table 76. Novartis Product
Table 77. Novartis Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 78. Novartis Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Product
Table 82. Pfizer Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 83. Pfizer Recent Development
Table 84. F. Hoffmann-La Roche Company Details
Table 85. F. Hoffmann-La Roche Business Overview
Table 86. F. Hoffmann-La Roche Product
Table 87. F. Hoffmann-La Roche Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 88. F. Hoffmann-La Roche Recent Development
Table 89. Celgene Company Details
Table 90. Celgene Business Overview
Table 91. Celgene Product
Table 92. Celgene Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 93. Celgene Recent Development
Table 94. AbbVie Company Details
Table 95. AbbVie Business Overview
Table 96. AbbVie Product
Table 97. AbbVie Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 98. AbbVie Recent Development
Table 99. Johnson & Johnson Company Details
Table 100. Johnson & Johnson Business Overview
Table 101. Johnson & Johnson Product
Table 102. Johnson & Johnson Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 103. Johnson & Johnson Recent Development
Table 104. Takeda Company Details
Table 105. Takeda Business Overview
Table 106. Takeda Product
Table 107. Takeda Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 108. Takeda Recent Development
Table 109. Alexion Business Overview
Table 110. Alexion Product
Table 111. Alexion Company Details
Table 112. Alexion Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 113. Alexion Recent Development
Table 114. Novo Nordisk Company Details
Table 115. Novo Nordisk Business Overview
Table 116. Novo Nordisk Product
Table 117. Novo Nordisk Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 118. Novo Nordisk Recent Development
Table 119. Sanofi Company Details
Table 120. Sanofi Business Overview
Table 121. Sanofi Product
Table 122. Sanofi Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 123. Sanofi Recent Development
Table 124. Bayer Company Details
Table 125. Bayer Business Overview
Table 126. Bayer Product
Table 127. Bayer Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 128. Bayer Recent Development
Table 129. Amgen Company Details
Table 130. Amgen Business Overview
Table 131. Amgen Product
Table 132. Amgen Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 133. Amgen Recent Development
Table 134. Allergan Company Details
Table 135. Allergan Business Overview
Table 136. Allergan Product
Table 137. Allergan Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 138. Allergan Recent Development
Table 139. Eisai Company Details
Table 140. Eisai Business Overview
Table 141. Eisai Product
Table 142. Eisai Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 143. Eisai Recent Development
Table 144. Bristol-Myers Squibb Company Details
Table 145. Bristol-Myers Squibb Business Overview
Table 146. Bristol-Myers Squibb Product
Table 147. Bristol-Myers Squibb Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 148. Bristol-Myers Squibb Recent Development
Table 149. Merck Company Details
Table 150. Merck Business Overview
Table 151. Merck Product
Table 152. Merck Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 153. Merck Recent Development
Table 154. Vertex Pharmaceuticals Company Details
Table 155. Vertex Pharmaceuticals Business Overview
Table 156. Vertex Pharmaceuticals Product
Table 157. Vertex Pharmaceuticals Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 158. Vertex Pharmaceuticals Recent Development
Table 159. Baxter Company Details
Table 160. Baxter Business Overview
Table 161. Baxter Product
Table 162. Baxter Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 163. Baxter Recent Development
Table 164. BioMarin Company Details
Table 165. BioMarin Business Overview
Table 166. BioMarin Product
Table 167. BioMarin Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 168. BioMarin Recent Development
Table 169. Teva Pharmaceutical Industries Company Details
Table 170. Teva Pharmaceutical Industries Business Overview
Table 171. Teva Pharmaceutical Industries Product
Table 172. Teva Pharmaceutical Industries Revenue in Rare Disease Treatment Business (2015-2020) (Million US$)
Table 173. Teva Pharmaceutical Industries Recent Development
Table 174. Research Programs/Design for This Report
Table 175. Key Data Information from Secondary Sources
Table 176. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Rare Disease Treatment Market Share by Type: 2020 VS 2026
Figure 2. Originator Drugs Features
Figure 3. Generic Drugs Features
Figure 4. Global Rare Disease Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Specialty Pharmacies Case Studies
Figure 7. Retail Pharmacies Case Studies
Figure 8. Rare Disease Treatment Report Years Considered
Figure 9. Global Rare Disease Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Rare Disease Treatment Market Share by Regions: 2020 VS 2026
Figure 11. Global Rare Disease Treatment Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Rare Disease Treatment Market Share by Players in 2019
Figure 14. Global Top Rare Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Rare Disease Treatment as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Rare Disease Treatment Revenue in 2019
Figure 16. North America Rare Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Rare Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Rare Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Rare Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Rare Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Rare Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Rare Disease Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed

以下、関連資料のご紹介

希少神経疾患治療の世界市場（～2026年）

Global Rare Neurological Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04460 2020年11月20日 98Pages
当調査資料は希少神経疾患治療のグローバル市場について調査・分析したレポートです。種類別（生物製剤、有機化合物）市場規模、用途別（病院薬局、小売薬局、オンライン薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オース...

希少内分泌疾患治療の世界市場（～2026年）

Global Rare Endocrine Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04459 2020年11月20日 94Pages
当調査資料は希少内分泌疾患治療のグローバル市場について調査・分析したレポートです。種類別（生物製剤、有機化合物）市場規模、用途別（病院薬局、オンライン薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

クラッベ病治療の世界市場（～2026年）

Global Krabbe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12467 2020年11月25日 94Pages
当調査資料はクラッベ病治療のグローバル市場について調査・分析したレポートです。種類別（抗けいれん薬、筋弛緩薬、造血幹細胞移植、その他）市場規模、用途別（病院、ASC）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オー...

人獣共通感染症治療の世界市場（～2026年）

Global Zoonotic Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY05134 2020年11月20日 93Pages
当調査資料は人獣共通感染症治療のグローバル市場について調査・分析したレポートです。種類別（ウイルス性肝炎、狂犬病、回帰熱、結核、マラリア）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、イン...

ニューカッスル病治療の世界市場（～2026年）

Global Newcastle Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY03968 2020年11月20日 99Pages
当調査資料はニューカッスル病治療のグローバル市場について調査・分析したレポートです。種類別（弱毒生ワクチン、不活化ワクチン、複合ワクチン）市場規模、用途別（獣医病院、獣医クリニック、獣医研究所、小売薬局、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、...

感染症治療の世界市場（～2026年）

Global Infectious Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY12367 2020年11月25日 91Pages
当調査資料は感染症治療のグローバル市場について調査・分析したレポートです。種類別（抗菌、抗真菌薬、抗ウイルス薬）市場規模、用途別（病院・クリニック、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリ...

クッシング病治療の世界市場（～2026年）

Global Cushing’s Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11540 2020年11月25日 99Pages
当調査資料はクッシング病治療のグローバル市場について調査・分析したレポートです。種類別（ケトコナゾール、ミトタン、アミノグルテチミド、メチラポン、ミフェプリストン、エトミデート、パシレオチド）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、クリニック、Eコマース/オンライン薬局）市場規模、地域...

ポンペ病治療の世界市場（～2026年）

Global Pompe Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04326 2020年11月20日 95Pages
当調査資料はポンペ病治療のグローバル市場について調査・分析したレポートです。種類別（乳児期発症ポンペ病、成人発症ポンペ病）市場規模、用途別（病院、医療センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オ...

ベーチェット病治療の世界市場（～2026年）

Global Behcet Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY11034 2020年11月25日 98Pages
当調査資料はベーチェット病治療のグローバル市場について調査・分析したレポートです。種類別（アダリムマブバイオシミラー、アプレミラスト、カナキヌマブ、インフリキシマブバイオシミラー、その他）市場規模、用途別（在宅介護、病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス...

パーキンソン病治療の世界市場（～2026年）

Global Parkinson's Disease Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04163 2020年11月20日 99Pages
当調査資料はパーキンソン病治療のグローバル市場について調査・分析したレポートです。種類別（レボドパ/カルビドパ、ドーパミン受容体作動薬、MAO阻害剤、COMT阻害剤、抗コリン作用薬）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタ...

希少神経疾患治療の世界市場（～2026年） Market Analysis and Insights: Global Rare Neurological Disease Treatment Market The global Rare Neurological Disease Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Rare Neurological Disease Treatment Scope a…
希少内分泌疾患治療の世界市場（～2026年） The endocrine system is a chemical messenger system consisting of hormones, the group of glands of an organism that carry those hormones directly into the circulatory system to be carried towards distant target organs and the feedback loops of homeostasis that the hormones drive. The rare endocrine …
クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…
感染症治療の世界市場（～2026年） Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Market Analysis and Insights: Global Infectious Disease Treatment M…
ニューカッスル病治療の世界市場（～2026年） Newcastle Disease is a highly contagious disease of avian species especially poultry caused by avian Paramyxovirus type 1 (APMV-1). The North America is dominating and contributed the leading shares to the global Newcastle Disease Treatment market in terms of revenue and expected to register a signi…